Quaker Hill, CT, United States of America

Kevin Paul Girard


 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kevin Paul Girard: Innovator in Pharmaceutical Chemistry

Introduction

Kevin Paul Girard is a notable inventor based in Quaker Hill, Connecticut. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on innovative compounds and their applications in medicine.

Latest Patents

Girard's latest patents include the invention of a novel p-toluenesulfonic acid salt and a crystalline polymorphic Form 1 of said salt. This invention pertains to a compound known as 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one. The patent also covers pharmaceutical compositions containing this compound, along with its preparations and uses. Additionally, he has developed solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole, which includes methods for their preparation and therapeutic applications.

Career Highlights

Kevin Paul Girard is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of innovative pharmaceutical solutions that address various health challenges.

Collaborations

Throughout his career, Girard has collaborated with talented individuals such as Andrew James Jensen and Kris Nicole Jones. These collaborations have fostered a creative environment that enhances the development of new pharmaceutical inventions.

Conclusion

Kevin Paul Girard is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions continue to impact the field positively, showcasing the importance of research and development in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…